Tru Independence Asset Management 2, LLC Abb Vie Inc. Transaction History

Tru Independence Asset Management 2, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $426,021 - $490,626	2,946 New	2,946 $469,000
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $271,249 - $344,846	-1,971 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $923 - $1,146	-7 Reduced 0.35%	1,971 $320,000
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $212,496 - $268,869	1,978 New	1,978 $268,000
Q1 2021 May 19, 2021	SELL	$102.3 - $112.62 $79,589 - $87,618	-778 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$80.49 - $108.67 $62,621 - $84,545	778 New	778 $83,000

3,870

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Tru Independence Asset Management 2, LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence Asset Management 2, LLC with notifications on news.